In addition, CEACAM1 controls insulin clearance to protect against insulin resistance, obesity, WAT-associated inflammation, hepatosteatosis (NAFLD), NASH, fibrosis and cardiovascular disease, as bolstered by observations in mice with global deletion of CEACAM1 expression. This evidence concerns the gene CEACAM1 and metabolic dysfunction-associated steatohepatitis.